Erik Jongert

4.5k total citations
47 papers, 2.2k citations indexed

About

Erik Jongert is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Erik Jongert has authored 47 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Immunology and 16 papers in Virology. Recurrent topics in Erik Jongert's work include Malaria Research and Control (14 papers), Toxoplasma gondii Research Studies (13 papers) and Herpesvirus Infections and Treatments (12 papers). Erik Jongert is often cited by papers focused on Malaria Research and Control (14 papers), Toxoplasma gondii Research Studies (13 papers) and Herpesvirus Infections and Treatments (12 papers). Erik Jongert collaborates with scholars based in Belgium, United States and United Kingdom. Erik Jongert's co-authors include Aize Kijlstra, Stéphane De Craeye, Philippe Moris, Eskild Petersen, Nicola Gargano, Robbert van der Most, Craig W. Roberts, Elisabeth Förster‐Waldl, Opokua Ofori‐Anyinam and Marie‐Ange Demoitié and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Erik Jongert

46 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Erik Jongert 999 973 730 567 489 47 2.2k
Isabelle Dimier‐Poisson 966 1.0× 716 0.7× 537 0.7× 217 0.4× 122 0.2× 77 1.9k
Arturo Reyes‐Sandoval 197 0.2× 792 0.8× 1.1k 1.5× 1.2k 2.1× 1.2k 2.5× 96 3.3k
W. Ripley Ballou 354 0.4× 749 0.8× 1.1k 1.5× 662 1.2× 2.1k 4.2× 48 3.5k
Marie‐Pierre Brenier‐Pinchart 1.9k 1.9× 1.6k 1.6× 201 0.3× 480 0.8× 276 0.6× 103 2.6k
Jorge Enrique Gómez‐Marín 2.2k 2.2× 1.3k 1.3× 115 0.2× 402 0.7× 361 0.7× 183 2.6k
Vladimir N. Loparev 396 0.4× 1.8k 1.8× 181 0.2× 505 0.9× 135 0.3× 74 2.5k
Dominique Buzoni–Gatel 1.2k 1.2× 1.0k 1.1× 972 1.3× 289 0.5× 77 0.2× 56 2.2k
Richard C. Hedstrom 351 0.4× 620 0.6× 1.6k 2.2× 575 1.0× 1.1k 2.2× 42 3.4k
Mario Lobigs 394 0.4× 900 0.9× 928 1.3× 2.6k 4.7× 3.0k 6.1× 82 4.3k
Sarah Sebastian 131 0.1× 532 0.5× 527 0.7× 484 0.9× 317 0.6× 35 1.5k

Countries citing papers authored by Erik Jongert

Since Specialization
Citations

This map shows the geographic impact of Erik Jongert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jongert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jongert more than expected).

Fields of papers citing papers by Erik Jongert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Jongert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jongert. The network helps show where Erik Jongert may publish in the future.

Co-authorship network of co-authors of Erik Jongert

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Jongert. A scholar is included among the top collaborators of Erik Jongert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Jongert. Erik Jongert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Alison, Dexter Wiseman, Corinne Vandermeulen, et al.. (2025). Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review. Expert Review of Clinical Immunology. 21(6). 745–760.
2.
Li, Kan, Michael Dodds, Rachel L. Spreng, et al.. (2023). A tool for evaluating heterogeneity in avidity of polyclonal antibodies. Frontiers in Immunology. 14. 1049673–1049673. 4 indexed citations
3.
Das, Jishnu, Jonathan K. Fallon, Timothy C. Yu, et al.. (2021). Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies. Med. 2(11). 1269–1286.e9. 19 indexed citations
4.
Seaton, Kelly E., Rachel L. Spreng, Sheetij Dutta, et al.. (2021). Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection. npj Vaccines. 6(1). 110–110. 13 indexed citations
5.
Pallikkuth, Suresh, Sidhartha Chaudhury, Pinyi Lu, et al.. (2020). A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. eLife. 9. 32 indexed citations
6.
Meeren, Olivier Van Der, Erik Jongert, Kelly E. Seaton, et al.. (2020). Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination. Vaccine. 38(7). 1678–1689. 3 indexed citations
7.
Kumarasamy, Nagalingeswaran, Selvamuthu Poongulali, Anne Bollaerts, et al.. (2018). Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults. Medicine. 97(45). e13120–e13120. 24 indexed citations
8.
Kumarasamy, Nagalingeswaran, Selvamuthu Poongulali, Anne Bollaerts, et al.. (2016). A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults. Medicine. 95(3). e2459–e2459. 35 indexed citations
9.
Lell, Bertrand, Sélidji Todagbé Agnandji, Kwaku Poku Asante, et al.. (2015). The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants. Malaria Journal. 14(1). 72–72. 21 indexed citations
10.
Leroux‐Roels, Geert, Isabel Leroux‐Roels, Frédéric Clément, et al.. (2014). Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines. Human Vaccines & Immunotherapeutics. 10(8). 2211–2219. 45 indexed citations
11.
Olotu, Ally, Frédéric Clément, Erik Jongert, et al.. (2014). Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01E in Young Children. PLoS ONE. 9(12). e115126–e115126. 18 indexed citations
12.
Spertini, François, R Audran, Opokua Ofori‐Anyinam, et al.. (2012). The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study. Tuberculosis. 93(2). 179–188. 42 indexed citations
13.
Ndungu, Francis M., Jedidah Mwacharo, Domtila Kimani, et al.. (2012). A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E. PLoS ONE. 7(12). e52870–e52870. 30 indexed citations
14.
Olotu, Ally, Philippe Moris, Jedidah Mwacharo, et al.. (2011). Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria. PLoS ONE. 6(10). e25786–e25786. 72 indexed citations
15.
Jongert, Erik, Arnaud Lemière, Jo A. Van Ginderachter, et al.. (2010). Functional characterization of in vivo effector CD4+ and CD8+ T cell responses in acute Toxoplasmosis: An interplay of IFN-γ and cytolytic T cells. Vaccine. 28(13). 2556–2564. 37 indexed citations
16.
Jongert, Erik, Craig W. Roberts, Nicola Gargano, Elisabeth Förster‐Waldl, & Eskild Petersen. (2009). Vaccines against Toxoplasma gondii: challenges and opportunities. Memórias do Instituto Oswaldo Cruz. 104(2). 252–266. 170 indexed citations
17.
Kijlstra, Aize, B.G. Meerburg, J.B.W.J. Cornelissen, et al.. (2008). The role of rodents and shrews in the transmission of Toxoplasma gondii to pigs. Veterinary Parasitology. 156(3-4). 183–190. 109 indexed citations
18.
Craeye, Stéphane De, et al.. (2008). Prevalence of Toxoplasma gondii infection in Belgian house cats. Veterinary Parasitology. 157(1-2). 128–132. 22 indexed citations
19.
Jongert, Erik, et al.. (2007). GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunology. 29(9). 445–453. 61 indexed citations
20.
Bivas‐Benita, Maytal, et al.. (2003). Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. International Journal of Pharmaceutics. 266(1-2). 17–27. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Dimier‐Poisson Breakdown of academic impact, for papers by Arturo Reyes‐Sandoval Breakdown of academic impact, for papers by W. Ripley Ballou Breakdown of academic impact, for papers by Marie‐Pierre Brenier‐Pinchart Breakdown of academic impact, for papers by Jorge Enrique Gómez‐Marín Breakdown of academic impact, for papers by Vladimir N. Loparev Breakdown of academic impact, for papers by Dominique Buzoni–Gatel Breakdown of academic impact, for papers by Richard C. Hedstrom Breakdown of academic impact, for papers by Mario Lobigs Breakdown of academic impact, for papers by Sarah Sebastian
Rankless by CCL
2026